Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Commentary, J Immunol Tech Infect Dis Vol: 2 Issue: 1
Pathogenesis of Dengue Thrombocytopenia: Prospective Challenges for Researchers
| Subhash C Arya* and Nirmala Agarwal | |
| Sant Parmanand Hospital, Delhi, India | |
| Corresponding author : Dr. Subhash C Arya Sant Parmanand Hospital, Delhi-110054, India E-mail: subhashbhapaji@gmail.com |
|
| Received: December 14, 2012 Accepted: January 21, 2013 Published: January 25, 2013 | |
| Citation: Arya SC, Agarwal N (2013) Pathogenesis of Dengue Thrombocytopenia: Prospective Challenges for Researchers. J Immunol Tech Infect Dis 2:1. doi:10.4172/2329-9541.1000104 |
Abstract
Pathogenesis of Dengue Thrombocytopenia: Prospective Challenges for Researchers
The incidence of dengue has grown dramatically around the world in recent decades. Over 2.5 billion people – over 40% of the world’s population – are now at risk from dengue. WHO currently estimates there may be 50-100 million dengue infections worldwide every year. Dengue Haemorrhagic Fever (DHF) affects most Asian and Latin American countries and has become a leading cause of hospitalization and death among children in these regions. There continues to be little emphasis on fundamental research on the genetic susceptibility of the host, pathogenesis of Dengue virus (DENV) associated thrombocytopenia, bleeding and plasma leakage.
